Ad-hoc | 4 August 2005 07:29

Fresenius AG: Excellent financial results; full-year earnings outlook raised

Ad hoc announcement §15 WpHG 1st half year 2005 Fresenius AG: Excellent financial results; full-year earnings outlook raised Ad hoc announcement transmitted by DGAP. The issuer is solely responsible for the content of this announcement. —————————————————————————— First half of 2005: Fresenius Group achieves excellent financial results and raises full-year earnings outlook Fresenius Group achieved excellent financial results in the first half of 2005. Sales rose 6 % in constant currency and 4 % at actual exchange rates to EUR 3,702 million (H1 2004: EUR 3,553 million). EBIT increased 12 % in constant currency and 10 % at actual exchange rates to EUR 453 million (H1 2004: EUR 412 million). Net income rose 28 % in constant currency and 26 % at actual exchange rates to EUR 101 million (H1 2004: EUR 80 million). Excellent operating results of Fresenius Medical Care and Fresenius Kabi, lower interest expenses and a slightly lower tax rate contributed to this increase. Earnings per ordinary share were EUR 2.46 (H1 2004: EUR 1.95). Earnings per preference share were EUR 2.48 (H1 2004: EUR 1.97). Based on these excellent results Fresenius raises its full-year outlook (before the acquisition of Renal Care Group by Fresenius Medical Care) and now expects net income growth of 20 to 25 % in constant currency. Previously, the Company expected 15 to 20 % net income growth. The projection for sales growth in constant currency remains at 6 to 9 %. The Management Board Bad Homburg v.d.H., August 4, 2005 Fresenius AG Else-Kröner-Straße 1 61352 Bad Homburg v.d.H. Deutschland ISIN: DE0005785638 (MDAX); DE0005785604 WKN: 578563; 578560 Listed: Amtlicher Markt in Düsseldorf, Frankfurt (Prime Standard) und München; Freiverkehr in Berlin-Bremen, Hamburg und Stuttgart End of ad hoc announcement (c)DGAP 04.08.2005 040729 Aug 05